Prof. Zhang Yi from the First Affiliated Hospital of Zhengzhou University (ZZU) leading his team, in collaboration with Academician Zhang Zemin’s team from Peking University’s Biomedical Pioneering Innovation Center, published a landmark study in the journalCellwith the titleA Single-cell Atlas Reveals Immune Heterogeneity in Anti-PD-1-treated Non-small Cell Lung Cancer. The research issponsored by China’s National Key R&D Program and National Natural Science Foundation.